US Stem Cell Inc (USRM)

[NoMoDo]

I bet we touch .07 then drop to the 200dma - low .05's. Then we trade in that range for a week or two. Then we test .09.

I think we see teens in Feb. April should provide the first Q with a real profit. By then the accounting depreciation and amortization numbers fall off the P&L. Even without RMAT, partnership, or an outright buyout, I believe we will see a quarter by the second week of April.

I hope to see real progress with the FDA before that time. Realistically, there are 4 different classifications of RMAT including fast track or even phase 4 approval. Fast track would likely still require a partnership, but USRM could realistically use the information they have already attained to gain phase 4. RMAT allows clinical as well as non-clinical data to be used to gain approval. Should they get phase 4 approval, USRM would be a buyout candidate at substantially higher prices.

Even if RMAT doesn't happen at all, we have Right to Try laws that provide a work around. Revenues for the K should be very nice. Also, additional clinics should be announced.